Literature DB >> 12637343

Human protease-activated receptor 1 expression in malignant epithelia: a role in invasiveness.

Yong-Jun Yin1, Zaidoun Salah, Sorina Grisaru-Granovsky, Irit Cohen, Sharona Cohen Even-Ram, Myriam Maoz, Beatrice Uziely, Tamar Peretz, Rachel Bar-Shavit.   

Abstract

While protease-activated receptors (PARs) play a traditional role in vascular biology, they emerge with surprisingly new assignments in tumor biology. PAR1 expression correlates with the invasion properties of breast carcinoma, whereas human PAR1 antisense reduces their ability to migrate through Matrigel. Part of the molecular mechanism of PAR1 invasion involves the formation of focal contact complexes on PAR1 activation. PAR1 induces angiogenesis in animal models in vivo and exhibits an oncogenic phenotype of enhanced ductal complexity when overexpressed in mouse mammary glands.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637343     DOI: 10.1161/01.ATV.0000066878.27340.22

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  20 in total

1.  Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets.

Authors:  Li Ma; Rafael Perini; Webb McKnight; Michael Dicay; Andre Klein; Morley D Hollenberg; John L Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-22       Impact factor: 11.205

2.  Thrombin expression in prostate: a novel finding.

Authors:  Manish Kohli; Karin Williams; Jorge L Yao; Richard A Dennis; Jiaoti Huang; Jay Reeder; William A Ricke
Journal:  Cancer Invest       Date:  2011-01       Impact factor: 2.176

3.  Oral thrombostatin FM19 inhibits prostate cancer.

Authors:  Marvin T Nieman; Gretchen LaRusch; Chao Fang; Yihua Zhou; Alvin H Schmaier
Journal:  Thromb Haemost       Date:  2010-09-30       Impact factor: 5.249

4.  Protease-activated receptors in cancer: A systematic review.

Authors:  Na Han; Ketao Jin; Kuifeng He; Jiang Cao; Lisong Teng
Journal:  Oncol Lett       Date:  2011-04-08       Impact factor: 2.967

5.  Etk/Bmx regulates proteinase-activated-receptor1 (PAR1) in breast cancer invasion: signaling partners, hierarchy and physiological significance.

Authors:  Irit Cohen; Myriam Maoz; Hagit Turm; Sorina Grisaru-Granovsky; Bella Maly; Beatrice Uziely; Einat Weiss; Rinat Abramovitch; Eithan Gross; Oded Barzilay; Yun Qiu; Rachel Bar-Shavit
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

6.  Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung.

Authors:  Tatjana M H Niers; Lois W Brüggemann; Clara P W Klerk; Femke J M Muller; Tessa Buckle; Pieter H Reitsma; Dick J Richel; C Arnold Spek; Olaf Van Tellingen; Cornelis J F Van Noorden
Journal:  Clin Exp Metastasis       Date:  2008-12-10       Impact factor: 5.150

7.  Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice.

Authors:  Henri H Versteeg; Florence Schaffner; Marjolein Kerver; Lesley G Ellies; Patricia Andrade-Gordon; Barbara M Mueller; Wolfram Ruf
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

8.  The proteolytic profile of human cancer procoagulant suggests that it promotes cancer metastasis at the level of activation rather than degradation.

Authors:  Nalise Low Ah Kee; Jason Krause; Gregory L Blatch; Koji Muramoto; Kazuo Sakka; Makiko Sakka; Ryno J Naudé; Leona Wagner; Raik Wolf; Jens-Ulrich Rahfeld; Hans-Ulrich Demuth; Wojciech P Mielicki; Carminita L Frost
Journal:  Protein J       Date:  2015-10       Impact factor: 2.371

9.  Haemostatic biomarkers for prognosis and prediction of therapy response in patients with metastatic colorectal cancer.

Authors:  Florian Moik; Florian Posch; Ella Grilz; Werner Scheithauer; Ingrid Pabinger; Gerald Prager; Cihan Ay
Journal:  Thromb Res       Date:  2020-01-07       Impact factor: 3.944

10.  Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1).

Authors:  Seok-Jun Kim; Ji-Young Shin; Kang-Duck Lee; Young-Ki Bae; Il-Ju Choi; Seok Hee Park; Kyung-Hee Chun
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.